Profile
Mr. Michael J.
Rechtiene is a Co-Chief Executive Officer at Therakos LLC and a President at Animas LLC.
Mr. Rechtiene was previously employed as a Principal by Johnson & Johnson, a Senior Advisor by PTV Sciences LP, and an Operating Advisor by Revival Healthcare Capital LLC.
He received his undergraduate degree from San Diego State University, an undergraduate degree from Villanova University and an MBA from The Wharton School of the University of Pennsylvania.
Michael Rechtiene active positions
| Companies | Position | Start |
|---|---|---|
Therakos, Inc.
Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Chief Executive Officer | - |
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Manufactures and distributes external insulin pumps for diabetes patients | President | - |
Former positions of Michael Rechtiene
| Companies | Position | End |
|---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Consultant / Advisor | 01/06/2023 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Healthcare Capital seeks invests in companies located in the United States. The firm focuses on companies operating in the fields of medical devices, healthcare services, and healthcare technology sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | - |
Training of Michael Rechtiene
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Manufactures and distributes external insulin pumps for diabetes patients | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Healthcare Capital seeks invests in companies located in the United States. The firm focuses on companies operating in the fields of medical devices, healthcare services, and healthcare technology sectors. It provides financing for early and later stage capital requirements. | Finance |
Therakos, Inc.
Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
- Stock Market
- Insiders
- Michael Rechtiene
















